Cheapest compounded vs brand-name GLP-1 (October 2026): lowest listed prices
Updated: 2026-10-29
Short answer: as of Oct 29, 2026 the lowest listed compounded price we found is $79/mo (semaglutide, CoreAge Rx: "from" price on its product page; its homepage advertises "from $99") and $129/mo (tirzepatide, CoreAge Rx and OurView Health). The lowest official brand self-pay prices are $149/mo for Wegovy® pill and Ozempic® pill (NovoCare, read Oct 17, 2026) and $149 for Foundayo per Lilly (read Oct 17, 2026); Zepbound® from $299 per 4 weeks (starting-dose vial), per LillyDirect, read Oct 17, reconfirmed Oct 22, 2026 — to be verified. Total cost may vary. CoreAge Rx is not promoted in Louisiana or Mississippi (restricted states for the program, per Katalys, Oct 26, 2026).
Compounded drugs are not FDA-approved and are not the same as brand-name drugs; they require a prescription. Not medical advice; we don't suggest doses. Ozempic® is FDA-approved for type 2 diabetes, not for weight loss. Wegovy® and Ozempic® are trademarks of Novo Nordisk; Zepbound®, Mounjaro® and Foundayo are trademarks of Eli Lilly and Company. GLP Claro is not affiliated with or endorsed by Novo Nordisk or Eli Lilly.
Sorted alphabetically by brand, not by price. GLP Claro is not affiliated with Novo Nordisk or Eli Lilly.
| Product (program) | Published price* | Source and check |
|---|---|---|
| Ozempic tablets (NovoCare) | from $149 | novocare.com · figure seen at source on 2026-10-29 |
| Ozempic (pen) (NovoCare) | to be verified | novocare.com · could not be re-read on 2026-10-29; data from 2026-10-17 |
| Wegovy (pill) (NovoCare) | from $149 | novocare.com · figure seen at source on 2026-10-29 |
| Wegovy (pen) (NovoCare) | from $349 | novocare.com · figure seen at source on 2026-10-29 |
| Zepbound (LillyDirect) | See price on lilly.com | lilly.com · the page returned a 403 error on 2026-10-29; we show no figure until it is read with a date · lilly.com |
* Manufacturer-published self-pay price, without insurance. No doses. Total cost may vary. Ozempic® and Wegovy® are trademarks of Novo Nordisk A/S; Zepbound® is a trademark of Eli Lilly and Company. Used descriptively only; GLP Claro is not affiliated with or endorsed by either company. Ozempic is FDA-approved for type 2 diabetes, not for weight loss.
What differs besides price
Brand-name drugs are FDA-approved for specific uses; compounded versions are not FDA-approved and are not generics. Read brand vs compounded.
Clinics with an FDA warning letter in the batches we reviewed (for example SkinnyRx, warning letter dated Feb 20, 2026) are left out of these lowest-price lists. Check fda.gov for any close-out letter.
Sources
class="small">Each clinic's own pricing page (linked in each row and on its profile), re-read on Oct 29, 2026; brand prices from NovoCare (novocare.com) and LillyDirect (lilly.com/lillydirect). Open data: clinics.json. See our methodology.FAQ
Is compounded cheaper than brand-name?
In our data as of Oct 29, 2026, the lowest listed compounded price ($79/mo, CoreAge Rx "from" price on its product page; its homepage advertises "from $99") is below the lowest official brand self-pay price ($149/mo). Total cost may vary.
Where do brand prices come from?
Only from official manufacturer programs: NovoCare (Novo Nordisk) and LillyDirect (Eli Lilly), with the date read. GLP Claro is not affiliated with either.
Is compounded the same as brand?
No. Compounded drugs are not FDA-approved and are not the same as the brand-name drug or a generic. Prescription required.